日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term risk of acute pancreatitis in patients with celiac disease: A nationwide population-based cohort study

乳糜泻患者发生急性胰腺炎的长期风险:一项全国性人群队列研究

Yao, Jialu; Sun, Jiangwei; Ebrahimi, Fahim; Bergman, David; Green, Peter H R; Lebwohl, Benjamin; Leffler, Daniel A; Sanders, David S; Lindkvist, Björn; Vujasinovic, Miroslav; Ludvigsson, Jonas F

Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies

Bimekizumab 在成人中轴型脊柱关节炎或银屑病关节炎患者中的长期安全性:六项 IIb/III 期临床研究的最新分析

Mease, Philip J; Merola, Joseph F; Magrey, Marina; Nash, Peter; Poddubnyy, Denis; Lebwohl, Mark; Bajracharya, Rajan; Ink, Barbara; Marten, Alexander; Manente, Myriam; Peterson, Luke; White, Katy; Gensler, Lianne S

Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment

使用索尼德吉和维莫德吉治疗基底细胞癌患者的真实世界治疗模式:停药率和治疗期间的临床状况

Lebwohl, Mark G; Rigel, Darrell S; Eroglu, Zeynep; Barghout, Victoria E; Gupta, Deepshekhar; Zanardo, Enrico; Huynh, Lynn; Yenikomshian, Mihran A; Squittieri, Nicholas; Ferro, Thomas J; Patel, Kunal

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year

比美珠单抗治疗伴有严重皮肤和指甲银屑病的银屑病关节炎患者的疗效和安全性(长达 1 年)

Thaçi, Diamant; Asahina, Akihiko; Boehncke, Wolf-Henning; Gottlieb, Alice B; Lebwohl, Mark; Warren, Richard B; Edens, Heather; Ink, Barbara; Bajracharya, Rajan; Coarse, Jason; Merola, Joseph F

Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2

Tildrakizumab治疗伴有糖尿病的中重度斑块状银屑病的疗效和安全性:reSURFACE 1和reSURFACE 2的汇总亚组分析

Bagel, Jerry; Gogineni, Ranga; Shaikh, Asif; Lebwohl, Mark G

Poster Session I - A110 TRENDS IN SPENDING ON ADVANCED IBD THERAPIES PRESCRIBED BY GASTROENTEROLOGISTS IN MEDICARE

海报展示环节 I - A110 医疗保险中胃肠病学家开具的先进炎症性肠病 (IBD) 疗法支出趋势

Blauvelt, Andrew; Gooderham, Melinda; Griffiths, Christopher E M; Armstrong, April W; Zhu, Baojin; Burge, Russel; Gallo, Gaia; Guo, Jiaying; Garrelts, Alyssa; Lebwohl, Mark; Raber, M; Lu, C; Ma, C; Nasser, Y; Congly, S

Risk of Nonmelanoma Skin Cancer in Patients with Moderate-to-Severe Atopic Dermatitis: A United States Population-Based Study

中重度特应性皮炎患者罹患非黑色素瘤皮肤癌的风险:一项基于美国人群的研究

Lebwohl, Mark; Yue, Emma; Krueger, Whitney S; Berman, Brian; Bunick, Christopher G; Schlesinger, Todd; Grada, Ayman

Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study

美国人群研究:特应性皮炎患者全身性糖皮质激素暴露情况

Bunick, Christopher G; Vleugels, Ruth Ann; Lebwohl, Mark; Armstrong, April W; Grada, Ayman; Yue, Emma Xiaomeng; Saranadasa, Madhi; Wegrzyn, Lani; D'Andrea, Elvira

The Increase of Early-Onset Colorectal Cancer: New Insights and Emerging Hypotheses

早发性结直肠癌发病率上升:新的见解和新兴的假设

Lee, Isaac; Bernstein, Ezra; Lebwohl, Benjamin; Neugut, Alfred I

Development of Celiac Disease After Immunotherapy: A Case Series

免疫治疗后乳糜泻的发生:病例系列

Malick, Alyyah; Lebwohl, Benjamin; Green, Peter H R; Lagana, Stephen M; Krishnareddy, Suneeta